NASDAQ:CTXR | Free Cash Flow | Citius Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$13.01M
2025-09-30-$11.88M
2024-12-31-$4.73M
2024-09-30-$5.91M
2023-12-31-$6.14M
2023-09-30-$6.8M
2022-12-31-$4.82M
2022-09-30-$6.33M
2021-12-31-$4.65M
2021-09-30-$5.59M$0.00-$5.59M
2020-12-31-$9.56M
2020-09-30-$3.36M$0.00-$3.36M
2019-12-31-$5.11M
2019-09-30-$2.91M
2018-12-31-$2.16M
2018-09-30-$2.5M
2017-12-31-$2.44M
2017-09-30-$3.43M
2016-12-31-$1.31M
2016-09-30-$1.77M
2015-12-31-$697,086.00
2015-09-30-$705,300.00
2014-12-31-$734,823.00
2014-09-30$419,665.00
2013-12-31-$521,882.00
2013-09-30-$7,396.00
2012-12-31-$236.00
2012-09-30-$5,448.00
2011-12-31-$2,196.00
2011-09-30-$4,941.00
2010-12-31-$3,041.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$26.55M
2024-09-30-$28.2M
2023-09-30-$29.06M
2022-09-30-$28.36M
2021-09-30-$24.25M$6,938.00-$24.26M
2020-09-30-$16.93M$1,831.00-$16.93M
2019-09-30-$12.44M
2018-09-30-$11.32M
2017-09-30-$7.97M$2,126.00-$7.97M
2016-09-30-$5.9M
2015-09-30-$2.39M
2014-09-30-$183,164.00
2013-12-31-$1.1M
2013-09-30-$20,604.00
2012-09-30-$20,324.00
2011-09-30-$20,781.00